Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Jun 27, 2026; 18(6): 118659
Published online Jun 27, 2026. doi: 10.4240/wjgs.118659
Published online Jun 27, 2026. doi: 10.4240/wjgs.118659
Table 3 Comparison of glucose metabolism indicators between the two groups (n = 40), mean ± SD
| Group | Glycated hemoglobin (%) | Fasting plasma glucose (mmol/L) | 2-hour postprandial glucose (mmol/L) | |||
| Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | |
| Control group | 8.95 ± 0.98 | 7.51 ± 0.84 | 10.12 ± 1.32 | 8.97 ± 1.25 | 14.87 ± 1.26 | 10.37 ± 1.69 |
| Observation group | 8.70 ± 1.04 | 6.13 ± 0.56 | 9.80 ± 1.69 | 6.04 ± 0.89 | 14.66 ± 1.67 | 8.52 ± 1.21 |
| t value | 1.099 | 8.642 | 0.944 | 12.094 | 0.626 | 5.615 |
| P value | 0.275 | < 0.001 | 0.348 | < 0.001 | 0.533 | < 0.001 |
- Citation: Li JP, Wang L, Dong L, Bai C. Impact of semaglutide with sleeve gastrectomy on blood glucose control and metabolism in obese type 2 diabetics. World J Gastrointest Surg 2026; 18(6): 118659
- URL: https://www.wjgnet.com/1948-9366/full/v18/i6/118659.htm
- DOI: https://dx.doi.org/10.4240/wjgs.118659